Agenda

Date and TimeTitle
Oct 28, 2021 (Eastern)
12:00pm - 12:47pm
Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?

Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information.

Sponsored by Novo Nordisk, Inc.

This is a Non CE/CME Presentation.

Oct 28, 2021 (Eastern)
1:00pm - 3:30pm
Visit Exhibit and Poster Halls

Click HERE to visit the exhibit hall.

Click HERE to visit the poster hall.

Oct 28, 2021 (Eastern)
3:30pm - 4:30pm
Addressing the Gap with Ready-to-Use Glucagon

Join Xeris Pharmaceuticals for an informative discussion that explores severe hypoglycemia management, the potential to change the current treatment approach for individuals at risk of severe hypoglycemic events, and the importance of co-prescribing glucagon with insulin.

Sponsored by Xeris 

This is a Non CE/CME Presentation

Oct 28, 2021 (Eastern)
4:30pm - 5:00pm
Visit Exhibit and Poster Halls

Click HERE to visit the exhibit hall.

Click HERE to visit the poster hall.

Oct 28, 2021 (Eastern)
5:00pm - 5:10pm
Conference Welcome and Introduction

5:00 pm ET | Welcome & Introduction
Lucia Novak, ANP-BC, BC-ADM and Scott Urquhart, PA-C, DFAAPA

Oct 28, 2021 (Eastern)
5:10pm - 6:10pm
Session I: Diabetes and Other Critical Considerations

5:10 pm ET | Session I Introduction
Scott Urquhart, PA-C, DFAAPA and Amy Butts, PA-C, BC-ADM

5:15 pm ET | Managing Diabetes in the Era of COVID-19: What We’ve Learned and What Works
Amy Butts, PA-C, BC-ADM

5:48 pm ET | Live Expert Commentary
Scott Urquhart, PA-C, DFAAPA and Amy Butts, PA-C, BC-ADM

ACCREDITATION STATEMENT 


In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians
Medscape, LLC designates this live event for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Physician Assistants
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.5 AAPA Category 1 CME credits. Approval is valid until 12/28/21. PAs should only claim credit commensurate with the extent of their participation.

For Nurses
Awarded 2.5 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.25 contact hours are in the area of pharmacology.

*Must complete Session I and Session I Continued for full credit.

Oct 28, 2021 (Eastern)
6:10pm - 6:30pm
Visit Exhibit and Poster Halls

Click HERE to visit the exhibit hall.

Click HERE to visit the poster hall.

Oct 28, 2021 (Eastern)
6:30pm - 7:45pm
Independent CME Symposium: Pearls for your Practice: Practical Strategies for Improving GLP-1 RA Use

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effective therapies for patients with type 2 diabetes (T2D) to decrease glycated hemoglobin (HbA1c) while promoting weight loss. This symposium will walk learners through the latest data and recommendations on GLP-1 RAs and provide tips to improve patient education and strategies to increase adherence.

Additional 1.25 hours of CME

Supported by an independent educational grant from Novo Nordisk, Inc.

CLICK HERE TO CLAIM CREDIT

Oct 28, 2021 (Eastern)
7:45pm - 8:00pm
Stretch Break

 

JOIN A 15 MINUTE STRETCH BREAK NOW!

*Please note that the stretch break will open in a new tab.

Session I Continued: Diabetes 

will begin at 8:00 PM ET.

Oct 28, 2021 (Eastern)
8:00pm - 9:50pm
Session I Continued: Diabetes and Other Critical Considerations

8:00 pm ET | Pre-diabetes and T2D -- Risk Factors, Screening, and Clinical Considerations
Lucia Novak, ANP-BC, BC-ADM

8:32 pm ET | The Cost and Cost Effectiveness of Managing Diabetes
Ashlyn Smith, PA-C

8:56 pm ET | Live Expert Commentary
Scott Urquhart, PA-C, DFAAPA and Amy Butts, PA-C, BC-ADM

9:01 pm ET | Adult-Onset Type 1 Diabetes: How Do I Proceed?
Davida Krueger, APN-BC, BC-ADM

9:19 pm ET | Live Q&A Discussion
Lucia Novak, ANP-BC, BC-ADM
Ashlyn Smith, PA-C

Scott Urquhart, PA-C, DFAAPA
Davida Krueger, APN-BC, BC-ADM

ACCREDITATION STATEMENT 


In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians
Medscape, LLC designates this live event for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Physician Assistants
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.5 AAPA Category 1 CME credits. Approval is valid until 12/28/21. PAs should only claim credit commensurate with the extent of their participation.

For Nurses
Awarded 2.5 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.25 contact hours are in the area of pharmacology.

*Must complete Session I and Session I Continued for full credit.

Oct 29, 2021 (Eastern)
11:00am - 12:00pm
Smart Insulin Pen Technology – Changing the Multiple Daily Injection (MDI) Landscape with Data and Decision-Making Support

Join us to learn more about smart insulin therapy featuring InPen™ Smart Insulin Pen. Topics of discussion will include:Building a data driven care approach with smart insulin pens to address the challenges of insulin therapy; How to have productive conversations with your insulin therapy patients using the InPen™ Insights Report; Putting it all together: Case study

Sponsored by Medtronic

This is a Non CE/CME Presentation.

Oct 29, 2021 (Eastern)
12:00pm - 12:45pm
Visit Exhibit and Poster Halls

Click HERE to visit the exhibit hall.

Click HERE to visit the poster hall.

Oct 29, 2021 (Eastern)
12:45pm - 1:45pm
Resolving Therapeutic Inertia Using Actionable CGM Guidance

The progressive nature of type 2 diabetes changes diabetes management over time in a variety of ways and is different for each person living with diabetes. Continuous glucose monitoring (CGM) provides a visual context to an individual’s current time-in-range and helps both the person and the healthcare professional identify areas to improve. This presentation will review the limitations of both A1C and blood glucose monitoring while highlighting the benefits of the Dexcom G6 real-time CGM system and Dexcom G6 Professional system in type 2 diabetes management. You will also learn to interpret Dexcom CLARITY reports through patient case studies, and how CLARITY data can be used for clinical guidance and therapeutic intervention. Learn to use CGM data and reports to inform treatment decisions via case studies

Sponsored by Dexcom

This is a Non CE/CME Presentation.

Oct 29, 2021 (Eastern)
1:45pm - 2:00pm
Visit Exhibit and Poster Halls

Click HERE to visit the exhibit hall.

Click HERE to visit the poster hall.

Oct 29, 2021 (Eastern)
2:00pm - 4:43pm
Session II: Diabetes and Non-Glycemic CVD/CKD Risk Reduction

2:00 pm ET | Introduction
Scott Urquhart, PA-C, DFAAPA
Lucia Novak, ANP-BC, BC-ADM

2:10 pm ET | Diabetic Kidney Disease -- New Guidelines and Clinical Applications
Kim Zuber, PA-C

2:50 pm ET | Live Q&A Discussion
Kim Zuber, PA-C
Scott Urquhart, PA-C, DFAAPA
Lucia Novak, ANP-BC, BC-ADM

3:10 pm ET | T2D and CVOTs : Diabetes and Non-Glycemic CVD/CKD Risk Reduction
Lucia Novak, ANP-BC, BC-ADM
Scott Urquhart, PA-C
Joyce Ross, CRNP, CLS

4:24 pm ET | Live Q&A Discussion
Lucia Novak, ANP-BC, BC-ADM
Scott Urquhart, PA-C
Joyce Ross, CRNP, CLS

ACCREDITATION STATEMENT 


In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians
Medscape, LLC designates this live event for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Physician Assistants
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.5 AAPA Category 1 CME credits. Approval is valid until 12/28/21. PAs should only claim credit commensurate with the extent of their participation.

For Nurses
Awarded 2.5 contact hour(s) of nursing continuing professional development for RNs and APNs; 2.0 contact hours are in the area of pharmacology.

 

Oct 29, 2021 (Eastern)
4:45pm - 5:00pm
Visit Exhibit and Poster Halls

Click HERE to visit the exhibit hall.

Click HERE to visit the poster hall.

Oct 29, 2021 (Eastern)
5:00pm - 5:30pm
Backstage Pass

Join our 30-minute post-session conversation connecting the program speakers and audience in an intimate interactive session where you can address case-based questions, gain valuable insights, and facilitate relationship building. Participation with video encouraged. This is a Non-CE/CME activity.

Oct 30, 2021 (Eastern)
10:00am - 10:30am
Visit Exhibit and Poster Halls

Click HERE to visit the exhibit hall.

Click HERE to visit the poster hall.

Oct 30, 2021 (Eastern)
10:30am - 1:07pm
Session III: Endocrine Case Studies

10:00 am ET | Introduction
Christine Kessler, ANP-BC, FAANP
Scott Urquhart, PA-C, DFAAPA

10:36 am ET | Thyroid Case Studies  (Part 1)

  • Hypothyroid (primary, other causes)
    Christine Kessler, ANP-BC, FAANP
  • Hyperthyroid (graves, toxic, nodules, others)
    Ashlyn Smith, PA-C

11:39 am ET | Live Expert Commentary
Christine Kessler, ANP-BC, FAANP
Scott Urquhart, PA-C, DFAAPA

11:49 am ET | Thyroid Case Studies  (Part 2)

  • Thyroiditis (post-partum, silent, subacute)
    David Doriguzzi, PA-C
  • Thyroid Nodules
    Scott Urquhart, PA-C, DFAAPA

12:47 pm ET | Live Q&A Discussion
David Doriguzzi, PA-C
Christine Kessler, ANP-BC, FAANP
Ashlyn Smith, PA-C
Scott Urquhart, PA-C, DFAAPA

Supported by an independent educational grant from Eton Pharmaceuticals

ACCREDITATION STATEMENT 


In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians
Medscape, LLC designates this live event for a maximum of 4.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Physician Assistants
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.25 AAPA Category 1 CME credits. Approval is valid until 12/28/21. PAs should only claim credit commensurate with the extent of their participation.

For Nurses
Awarded 4.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.5 contact hours are in the area of pharmacology.

*Must complete Session III and Session III Continued for full credit.

Oct 30, 2021 (Eastern)
1:07pm - 1:20pm
Visit Exhibit and Poster Halls

Click HERE to visit the exhibit hall.

Click HERE to visit the poster hall.

Oct 30, 2021 (Eastern)
1:20pm - 2:50pm
Session III Continued: Endocrine Case Studies

1:20 pm ET | LIVE: MEDS Challenge: Thyroid Case Studies
David Doriguzzi, PA-C
Ashlyn Smith, PA-C
Christine Kessler, ANP-BC, FAANP
Scott Urquhart, PA-C, DFAAPA

2:00 pm ET | Pediatric Adrenal Insufficiency
Ashlyn Smith, PA-C

2:26 pm ET | Live Q&A Discussion
David Doriguzzi, PA-C
Ashlyn Smith, PA-C
Christine Kessler, ANP-BC, FAANP
Scott Urquhart, PA-C, DFAAPA

2:46 pm ET | Closing Remards
Lucia Novak, ANP-BC, BC-ADM
Christine Kessler, ANP-BC, FAANP

Supported by an independent educational grant from Eton Pharmaceuticals

ACCREDITATION STATEMENT 


In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians
Medscape, LLC designates this live event for a maximum of 4.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Physician Assistants
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.25 AAPA Category 1 CME credits. Approval is valid until 12/28/21. PAs should only claim credit commensurate with the extent of their participation.

For Nurses
Awarded 4.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.5 contact hours are in the area of pharmacology.

*Must complete Session III and Session III Continued for full credit.

Nov 18, 2021 (Eastern)
9:00am - 10:00am
Session I Enduring: Diabetes and Other Critical Considerations
Nov 18, 2021 (Eastern)
9:05am - 10:05am
Session II Enduring: Diabetes and Non-Glycemic CVD/CKD Risk Reduction
Nov 18, 2021 (Eastern)
11:10am - 12:10pm
Session III Enduring: Endocrine Case Studies